Skip to content
value.today

Wheeler Bio, Inc.

Formerly Wheeler Bio, LLC, Wheeler Labs, LLC

Total raised
$60 M
3 rounds on record
Latest round
$23 M
Mar 2025
First round on record
Nov 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Wheeler Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$23 MNo. 3$10 to $50 million

Wheeler Bio, Inc.: Raise no. 3, Mar 2025

Investors in this round

18 investors had bought by the notice of Apr 25, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $37 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Keith McCormick · Executive Officer
  • Patrick Lucy · Executive Officer, Director
  • Errik Anderson · Director
  • M. Christian Kanady · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Shares of Series A-1 and Series A-2 Preferred Stock, and the Common Stock issuable upon conversion thereof.”

Signed by Patrick Lucy, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 25, 2025. Read the notice at the SEC.

equitySEC
Sep 2022$23 MNo. 2$10 to $50 million

Wheeler Bio, Inc.: Raise no. 2, Sep 2022

Investors in this round

8 investors had bought by the notice of Oct 11, 2022: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $30 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse McCool · Executive Officer, Director
  • Joshua Hood · Executive Officer
  • Matt Hamilton · Executive Officer
  • Stephen Hamilton · Executive Officer
  • Yuk Chun Chiu · Executive Officer
  • Errik Anderson · Director
  • M. Christian Kanady · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A Preferred Stock, and the Common Stock issuable upon conversion thereof.”

Signed by Jesse McCool, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 11, 2022. Read the notice at the SEC.

equitySEC
Nov 2021$14 MNo. 1$10 to $50 million

Wheeler Bio, Inc.: Raise no. 1, Nov 2021

Investors in this round

10 investors had bought by the notice of Nov 23, 2021: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $15 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse McCool · Executive Officer
  • Joshua Hood · Executive Officer
  • Joshua Merrill · Executive Officer
  • Stephen Hamilton · Executive Officer
  • Yuk Chun Chiu · Executive Officer
  • Errik Anderson · Director
  • M. Christian Kanady · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series Seed-2 Preferred Stock, and the Common Stock issuable upon conversion thereof.”

Signed by Jesse McCool, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 23, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Wheeler Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2025).

    SEC Form D · Apr 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · Apr 2025

That is all the official record says: Wheeler Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Wheeler Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 18 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Wheeler Bio, Inc.
NameRoleNamed in
Keith McCormickExecutive officerApr 2025
Patrick LucyExecutive officerApr 2025
Jesse McCoolExecutive officerOct 2022
Joshua HoodExecutive officerOct 2022
Matt HamiltonExecutive officerOct 2022
Stephen HamiltonExecutive officerOct 2022
Yuk Chun ChiuExecutive officerOct 2022
Joshua MerrillExecutive officerNov 2021
Errik AndersonDirectorApr 2025
M. Christian KanadyDirectorApr 2025
Patrick LucyDirectorApr 2025
Jesse McCoolDirectorOct 2022